2min chapter

Breakpoints cover image

#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials

Breakpoints

CHAPTER

The Eradicate Trial for Staff Arias Bacteremia

This is Ceph de Bipril compared to Daptomycin with or without optional as tree name for the treatment of complicated staff, Arias Bacteremia. This was presented by none other than Dr. Tom Holland, who's an associate professor in the division of ID at Duke University Medical Center. Unlike the last trial that got dapedo, it's approval in 2006. And I don't know about y'all, but when I started doing this math, I think I was in junior high when that happened.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode